BMS looks forward to pivotal readouts for six assets in 2026, ensuring profits after patent expiries for Opdivo and Eliquis.

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

Mana Shankara Vara Prasad Garu has joined the likes of They Call Him OG and other Telugu biggies on BMS. Read box office updates!

Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. | SAN FRANCISCO—Bristol Myers Squibb is ...

The portable energy solutions company introduced its latest high-capacity power station at the technology showcase, featuring ...

The Fourth Annual Mark Starr Cutter Classic will take place Saturday, Jan. 24, in the Quarry Gymnasium at Bedford Middle ...

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...

Ranveer Singh's Dhurandhar has surpassed RRR in ticket sales on BookMyShow. Check out the complete list of top 10.

Gallagher Re has confirmed its recruitment of Georgina Meyer as executive director for UK property. This publication reported ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to ...

Set for multiple late-stage readouts in oncology in 2026, BioNTech is entering a crucial phase of its roadmap beyond Covid-19 ...